Agencies, 28 September: Tinta hospitals te clinical trial low ate COVID-9 patients ke natural treatment deya te besi phak symptoms toh conventional medicines para be besi phal howa paise.
Corival Life Sciences para Ayurvedic remedy ‘Immunofree’ kowa te aro Biogetica para Nutraceutical ‘Reginmune’ kowa te treatment lowa te ektum phal results paise. Etu toh aji kali COVID-19 treatment nemide government SOP of conventional medicines para be phal howa paise.
Aro novel coronavirus nemide besi test- C reactive protein, Procalcitonin, D Dimer aro RT-PCR – nesana lowa te 20 to 60 per cent phal howa toh natural treatment te paise. Etu toh conventional treatment te compared kora te ase. Aro gao bekha aro sash lobole napara nesana be natural treatment te phal hoi thaka paise.
Clinician’s Global Assessment of Symptoms aro Subject’s Global Assessment of Symptoms te sabha-sabhi dekhise, phal hoi thaka toh test group te besi kaam laga data dekha.
5 din te 86.66 percent laga patients toh national protocol te corona negative olaise aro conventional treatments te shaijaile (compared) 60 percent patients thakise.
10th din test te, sob patients toh negative olaise. Etu para hospitals te besi busy narakhibo nemide motob debo pari.
Immunofree aro Reginmune toh India te tinta hospitals te study korise.
Etu CTRI-approved toh moderate COVID-19 positive te loise. Etu toh Government Medical Hospital, Srikakulam Andhra Pradesh, Parul Sevashram Hospital, Vadodara, Gujarat, aro Lokmanya Hospital Pune, Maharashtra jaga te loise.
Add Comment